Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 7:18 PM
Ignite Modification Date: 2025-12-24 @ 7:18 PM
NCT ID: NCT03848403
Eligibility Criteria: Inclusion Criteria: * Healthy male participants or female participants who agree not to get pregnant * Are male participants or female participants with chronic, stable medical problems that, in the investigator's opinion, will not place the participant at increased risk by participating in the study Exclusion Criteria: * Have a significant history of, or current, cardiovascular, respiratory, hepatic, renal, gastrointestinal, endocrine, or hematologic disorders that in the opinion of the investigator poses an unacceptable risk to the participant if participating in the study * Are allergic or hypersensitive to the study medicine * Have dullness or loss of sensitivity on either side of your abdomen * Have any condition that could affect pain perception from an injection * Had a vaccination with a live vaccine within 12 months prior to the first check-in or intend to get a vaccine for tuberculosis within 12 months of completing treatment on this study * Have any type of hepatitis, human immunodeficiency virus (HIV) infection, or other serious infection * Show evidence of active or latent tuberculosis (TB) * Presence of significant neuropsychiatric disorder or a recent history of depression * Have excessive tattoos or scars over the abdomen or other factors such as rash or excessive folds of skin that would interfere with injection site assessments * Have had any active or recent infection within 4 weeks of Day 1 that, in the opinion of the investigator would pose an unacceptable risk to the participant if participating in the study
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 75 Years
Study: NCT03848403
Study Brief:
Protocol Section: NCT03848403